Find a Trial
Trial Summary
| Protocol No. | CTO-CTMX-2009-002 | ||
|---|---|---|---|
| Status | OPEN TO ACCRUAL | ||
| Principal Investigator | Miller, Kathy | ||
| Scope | National | ||
| Phase | Phase II | ||
| Age Group | Adult | ||
| Title | A Phase 2, Open-Label Study to Evaluate the Safety and Antitumor Activity of CX-2009 in Advanced HR-Positive/HER2-Negative Breast Cancer and of CX-2009 as Monotherapy and in Combination with CX-072 in Advanced Triple-Negative Breast Cancer (CTMX-2009-002) | ||
| Applicable Disease Sites | Breast | ||
| Participating Institutions | IU Health North Hospital | ||
| Treatment Type | Treatment | ||
| Contact | Phone: (317) 278-5632 Email: iutrials@iu.edu | ||